
Loading, please wait...

Loading, please wait...

Effective schistosomiasis biological control relies on understanding the complex predator-prey dynamics between natural enemies and intermediate snail hosts. While preventive chemotherapy with praziquantel remains the primary global strategy, rapid reinfection often persists in endemic settings. Consequently, public health experts are investigating biological interventions to reduce snail populations and interrupt the parasite's transmission cycle.
A recent laboratory study evaluated the predatory potential of the North American crayfish, Procambarus clarkii, against schistosome-transmitting snails. The findings suggest that these crayfish do not hunt randomly. Instead, they exhibit a significant preference for snails already infected with schistosomes. Specifically, infected snails were consumed in 64.3% of early-time predation events compared to only 35.7% for uninfected snails. This targeted predation is critical because it removes the most dangerous individuals from the freshwater ecosystem.
Moreover, the research identified size-selective behavior among the predators. Adult and sub-adult crayfish preferentially consumed larger snails, specifically those in the 7-12 mm range. While they did not show a preference between different snail species, their ability to clear infected snails faster—with a median depletion time of 18 hours versus 20 hours—highlights their efficiency. These results suggest that introducing or managing P. clarkii populations could complement existing mass drug administration programs.
For clinicians and public health officials in India, where sporadic cases of schistosomiasis and cercarial dermatitis occur, these findings emphasize the One Health approach. In addition to treating patients, managing the environment through biological agents can offer a sustainable solution. However, experts must also consider the invasive nature of P. clarkii before widespread implementation. Proper ecological monitoring is necessary to ensure that biological control does not lead to unintended biodiversity loss in local water bodies.
Research suggests that infected snails may exhibit altered physiological or behavioral traits, such as reduced movement or different chemical signals. These changes likely make them easier targets for crayfish during foraging.
While effective at snail control, this crayfish is an invasive species. Authorities must conduct thorough environmental impact assessments before utilizing it for vector control in non-native regions like India.
No, biological control is a complementary strategy. It reduces the transmission rate in the water, but medical treatment remains essential to cure individuals already harboring the adult worms.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a recommendation for any specific public health intervention. Refer to the latest local and national guidelines for clinical practice.
References
Murai Maina G et al. Predation preference of the crayfish Procambarus clarkii on schistosomiasis transmitting snails: influence of snail species, infection status, and size. Trop Med Health. 2026 May 14. doi: 10.1186/s41182-026-00970-2. PMID: 42135823.
World Health Organization. Schistosomiasis - World Health Organization (WHO). 2026 Feb 23. Available from: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
Mkoji GM et al. Impact of the crayfish Procambarus clarkii on Schistosoma haematobium transmission in Kenya. Am J Trop Med Hyg. 1999 Nov;61(5):751-9. doi: 10.4269/ajtmh.1999.61.751.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that Procambarus clarkii crayfish prefer preying on infected and larger snails, offering a boost to schistosomiasis biological control....
5 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today